Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer
NCT00139191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2009-11-02
Summary
The purpose of this study is to understand if a new type of radiology test called positron emission tomography (PET) with carbon 11 acetate will help us to understand which cancers produce more of a protein called fatty acid synthase (FAS).
Conditions
Interventions
- PROCEDURE
-
C-11 acetate PET scan
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
collaborator OTHER -
Massachusetts General Hospital
collaborator OTHER - lead OTHER
Principal Investigators
-
Robert Ross, MD · Dana-Farber Cancer Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Completion
- 2006-05-31
Countries
- United States
Study Locations
More Related Trials
-
PET Scan in Treating Patients With Metastatic Prostate Cancer
NCT00002981 ·Status: COMPLETED ·Phase: NA
-
Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer
NCT01543659 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer
NCT00804245 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of C-11 Choline PET in Patients With Prostate Cancer
NCT02852122 ·Status: COMPLETED ·Phase: NA
-
11C- and 18F-Choline PET/MR Imaging for Prostate Cancer
NCT02397408 ·Status: COMPLETED ·Phase: PHASE2
-
Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure.
NCT06168890 ·Status: COMPLETED
-
18F-DCFPyL PET-CT Scan and Prostate Cancer
NCT03852654 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer
NCT01132599 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Fapi-pet in Prostate Cancer.
NCT05192694 ·Status: UNKNOWN ·Phase: NA
-
Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer
NCT03793543 ·Status: COMPLETED ·Phase: PHASE1
-
C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma
NCT01530269 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer
NCT01815515 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer
NCT01119118 ·Status: TERMINATED ·Phase: PHASE2
-
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
NCT00956163 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer
NCT04809584 ·Status: APPROVED_FOR_MARKETING
-
18F-fluorocholine and 18F-fluoride PET in Prostate Cancer
NCT04340765 ·Status: COMPLETED ·Phase: NA
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer
NCT01089881 ·Status: UNKNOWN
-
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer
NCT04390880 ·Status: COMPLETED ·Phase: PHASE2
-
FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer
NCT00282906 ·Status: COMPLETED ·Phase: NA
-
[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases
NCT00670527 ·Status: UNKNOWN ·Phase: NA
-
Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases
NCT00936975 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
NCT06099093 ·Status: RECRUITING ·Phase: PHASE4
-
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies
NCT04158245 ·Status: COMPLETED ·Phase: PHASE2